Tenet Healthcare Corporation's stock has fallen 22.7% recently, but it remains a compelling Buy due to strong financial performance and a valuation discount compared to peers. The Ambulatory Care segment showed resilience with revenue rising from $1.19B to $1.32B and profit growth. Management projects 2026 revenue between $21.5B and $22.3B, EBITDA of $4.485B to $4.785B, and adjusted net profits of $1.425B to $1.625B. Although proposed Medicaid payment reforms pose regulatory risks to Hospital Operations, the company's valuation offers a margin of safety for investors to stay bullish.
AllianceBernstein Global High Income Fund, Inc. released its monthly portfolio update as of June 30, 2026, detailing its top fixed-income holdings and sector allocations. The fund holds a diversified portfolio with significant exposure to non-investm...
Tenet Healthcare Corporation reported strong Q2 2026 results, with earnings per share of $6.12, surpassing analyst estimates of $4.26 by a wide margin. Revenue also exceeded expectations at $5.63 billion, showing growth from the previous year. The co...
